Medican Enterprises, Inc.
MDCN
$0.00
$0.000.00%
OTC PK
| 03/31/2015 | 12/31/2014 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -43.99% | 4.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -43.99% | 4.50% | |||
| Operating Income | 43.99% | -4.50% | |||
| Income Before Tax | -1,123.32% | -3.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1,123.32% | -3.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,123.32% | -3.28% | |||
| EBIT | 43.99% | -4.50% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -260.70% | 2.54% | |||
| Normalized Basic EPS | -265.13% | 3.72% | |||
| EPS Diluted | -260.70% | 2.54% | |||
| Normalized Diluted EPS | -265.13% | 3.72% | |||
| Average Basic Shares Outstanding | 239.14% | 5.97% | |||
| Average Diluted Shares Outstanding | 239.14% | 5.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||